FUTURE PAK FDA Approval ANDA 070999

ANDA 070999

FUTURE PAK

FDA Drug Application

Application #070999

Application Sponsors

ANDA 070999FUTURE PAK

Marketing Status

Discontinued001

Application Products

001TABLET, EXTENDED RELEASE;ORAL10MEQ0K+10POTASSIUM CHLORIDE

FDA Submissions

ORIG1AP1987-10-22
BIOEQUIV; BioequivalenceSUPPL4AP1992-11-16
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1994-07-22
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1995-06-23
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1995-06-23

Submissions Property Types

SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0

CDER Filings

FUTURE PAK
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 70999
            [companyName] => FUTURE PAK
            [docInserts] => ["",""]
            [products] => [{"drugName":"K+10","activeIngredients":"POTASSIUM CHLORIDE","strength":"10MEQ","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"K+10","submission":"POTASSIUM CHLORIDE","actionType":"10MEQ","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2020-11-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.